Hims & Hers Health insider plans modest 2,100-share sale via Form 144

Rhea-AI Filing Summary

The Form 144 filing indicates that an insider, Michael Y. Chi, plans to sell up to 2,100 Class A shares of Hims & Hers Health, Inc. (HIMS) through Fidelity Brokerage on or about 24 Jul 2025. At the prevailing price used in the form, the proposed sale is valued at $120,792. With 215,453,899 Class A shares outstanding, the transaction represents roughly 0.001 % of the public float.

Chi acquired the shares via an employee stock option granted 24 Feb 2022 and exercised for cash on 24 Jul 2025. The filing also discloses prior insider activity:

• 5100 shares sold 06 Jun 2025 for $285,600
• 5400 shares sold 10 Jun 2025 for $307,800
• 17,102 shares sold 17 Jun 2025 for $1,021,844.50
• 13,750 shares sold 23 Jul 2025 for $770,000

Total sales over the last three months equal 41,352 shares (≈0.02 % of shares outstanding) for proceeds of about $2.39 million.

The notice affirms the seller is not aware of undisclosed adverse information. While continued insider selling may warrant monitoring, the volume remains immaterial relative to the company’s capitalization and is unlikely to affect trading dynamics on its own.

Insights

Securities Analyst

TL;DR: Small insider sale (~0.001 % float) adds to recent activity; negligible direct impact but trend worth tracking.

The proposed 2,100-share sale is economically insignificant for HIMS, equating to ~$121k against a multi-billion-dollar market cap. Combined with 41k shares already sold this quarter, Chi’s total disposals remain under 0.03 % of outstanding shares—well below levels that typically pressure liquidity or signal strategic shifts. Nevertheless, serial insider sales can influence sentiment if mirrored by other executives. No red flags such as 10b5-1 plan adoption dates or undisclosed adverse knowledge are apparent. Overall effect: neutral.

Corporate Governance Expert

TL;DR: Routine option-related sale; governance risk low, materiality minimal.

The filing shows exercise-and-sell following a 2022 option grant—standard practice for liquidity and tax. Absence of relationship details limits assessment of strategic motives, but the representation clause mitigates information-asymmetry concerns. Volumes are far below Rule 144 aggregation thresholds that might trigger market scrutiny. I view the action as ordinary-course insider monetization with no governance alarm.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2100	120792.00	215453899	07/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	07/24/2025	Option Granted 02/24/2022	Issuer			2100	07/24/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/06/2025	5100	285600.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/10/2025	5400	307800.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	17102	1021844.50
Michael Y. Chi 2269 Chestnut Street 523 San Francisco CA 94123	Class A	07/23/2025	13750	770000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many HIMS shares does Michael Y. Chi plan to sell under this Form 144?

The notice covers 2,100 Class A shares, valued at approximately $120,792.

What percentage of Hims & Hers Health’s outstanding shares does the sale represent?

Only about 0.001 % of the 215.45 million Class A shares outstanding.

How much stock has the insider already sold in the last three months?

Chi sold 41,352 shares between 6 Jun 2025 and 23 Jul 2025 for roughly $2.39 million in gross proceeds.

When were the shares to be sold originally acquired?

They were acquired on 24 Jul 2025 via an option granted on 24 Feb 2022.

Which broker will handle the proposed transaction?

The filing lists Fidelity Brokerage Services LLC, Smithfield, RI.

Does the filing indicate any undisclosed adverse information?

No. The signer certifies that they possess no material non-public adverse information about HIMS.